Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04199390 · ClinicalTrials.gov registry record · NA

Physical Therapy Following Total Hip Arthroplasty

A NA study of Surgery and Hip Osteoarthritis, sponsored by Orthopedic One.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT04199390 is a NA study of Surgery and Hip Osteoarthritis that has completed, run by Orthopedic One. The registered enrollment target is 130 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04199390, a NA study of Surgery and Hip Osteoarthritis, has completed, sponsored by Orthopedic One.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

130 patients undergoing primary unilateral total hip arthroplasty through anterior approach were enrolled and randomized into one of two groups. One group received standard of care clinic-based physical therapy postoperatively (clinic PT) while the other group underwent progressive home-based exercises to do after surgery (home PT). Patient surveys with Hip Osteoarthritis Outcome Scores (HOOS) and SF12v2 scores for both groups were obtained before surgery as well as 6, 14, and 24 weeks postop. Patients had the option to crossover into the other study group at their 6-week follow-up visit.

Interventions

  • PROCEDURE total hip arthroplasty

Study Locations (1)

Ohio

  • Orthopedic One - Dublin

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2018-07-31
Est. Completion 2019-10-07
Phase NA

Sponsor

Orthopedic One

1 total trials

What the Registry Record Tells You About NCT04199390

The ClinicalTrials.gov registry entry for NCT04199390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Orthopedic One, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which total hip arthroplasty is the first listed.

NCT04199390 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04199390 about?

NCT04199390 is a clinical study titled "Physical Therapy Following Total Hip Arthroplasty". 130 patients undergoing primary unilateral total hip arthroplasty through anterior approach were enrolled and randomized into one of two groups. One group received standard of care clinic-based physical therapy postoperatively (clinic PT) while the other group underwent progressive home-based exerci...

What is the current status of trial NCT04199390?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2018-07-31. Estimated completion is 2019-10-07.

What conditions does trial NCT04199390 study?

This clinical trial studies the following conditions: Surgery, Hip Osteoarthritis.

What interventions are being tested in trial NCT04199390?

The interventions under investigation include: total hip arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT04199390?

This trial is sponsored by Orthopedic One, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04199390 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.